Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–62. https://doi.org/10.1016/s0140-6736(22)01200-4.

Article  CAS  PubMed  Google Scholar 

Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–62. https://doi.org/10.1056/NEJMra1713263.

Article  CAS  PubMed  Google Scholar 

Jiang D, Ma X, Zhang X, et al. New techniques: a roadmap for the development of HCC immunotherapy. Front Immunol. 2023;14:1121162. https://doi.org/10.3389/fimmu.2023.1121162.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103–17. https://doi.org/10.1146/annurev-med-090514-013832.

Article  CAS  PubMed  Google Scholar 

Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410–20. https://doi.org/10.1001/jamasurg.2022.7989.

Article  PubMed  Google Scholar 

Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371: m3544. https://doi.org/10.1136/bmj.m3544.

Article  PubMed  Google Scholar 

Tang W, Chen Z, Zhang W, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. https://doi.org/10.1038/s41392-020-0187-x.

Article  PubMed  PubMed Central  Google Scholar 

Llovet JM, Castet F, Heikenwalder M, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19(3):151–72. https://doi.org/10.1038/s41571-021-00573-2.

Article  CAS  PubMed  Google Scholar 

Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187(2):235–56. https://doi.org/10.1016/j.cell.2023.11.044.

Article  CAS  PubMed  Google Scholar 

D’Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582–92. https://doi.org/10.1002/cbin.11137.

Article  PubMed  Google Scholar 

Peng F, Liao M, Qin R, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286. https://doi.org/10.1038/s41392-022-01110-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022;232: 108010. https://doi.org/10.1016/j.pharmthera.2021.108010.

Article  CAS  PubMed  Google Scholar 

Tong X, Tang R, Xiao M, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174. https://doi.org/10.1186/s13045-022-01392-3.

Article  PubMed  PubMed Central  Google Scholar 

Liao M, Qin R, Huang W, et al. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. J Hematol Oncol. 2022;15(1):44. https://doi.org/10.1186/s13045-022-01260-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu J, Guo C, Ruan J, et al. From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death. Apoptosis. 2024. https://doi.org/10.1007/s10495-023-01927-0.

Article  PubMed  Google Scholar 

Hsieh MY, Hsu SK, Liu TY, Wu CY, Chiu CC. Melanoma biology and treatment: a review of novel regulated cell death-based approaches. Cancer Cell Int. 2024;24(1):63. https://doi.org/10.1186/s12935-024-03220-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Y, Lian T, Huang Q, et al. Nanomedicine-mediated regulated cell death in cancer immunotherapy. J Control Release. 2023;364:174–94. https://doi.org/10.1016/j.jconrel.2023.10.032.

Article  CAS  PubMed  Google Scholar 

Ai L, Yi N, Qiu C, et al. Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review). Int J Oncol. 2024. https://doi.org/10.3892/ijo.2024.5634.

Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Xu X, Liu K, et al. Immunogenic cell death in hematological malignancy therapy. Adv Sci (Weinh). 2023;10(13): e2207475. https://doi.org/10.1002/advs.202207475.

Article  CAS  PubMed  Google Scholar 

Fang W, Xie S, Deng W. Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future. Cell Biol Toxicol. 2024;40(1):17. https://doi.org/10.1007/s10565-024-09853-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bian W, Li H, Chen Y, et al. Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL. Biomed Pharmacother. 2024;173: 116386. https://doi.org/10.1016/j.biopha.2024.116386.

Article  CAS  PubMed  Google Scholar 

Yue Z, Yuan Y, Zhou Q, Sheng J, Xin L. Ferroptosis and its current progress in gastric cancer. Front Cell Dev Biol. 2024;12:1289335. https://doi.org/10.3389/fcell.2024.1289335.

Article  PubMed  PubMed Central  Google Scholar 

Khan F, Pandey P, Verma M, et al. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Biomed Pharmacother. 2024;173: 116363. https://doi.org/10.1016/j.biopha.2024.116363.

Article  CAS  PubMed  Google Scholar 

Xu Q, Ren L, Ren N, et al. Ferroptosis: a new promising target for hepatocellular carcinoma therapy. Mol Cell Biochem. 2023. https://doi.org/10.1007/s11010-023-04893-y.

Article  PubMed  PubMed Central  Google Scholar 

Tang B, Zhu J, Wang Y, et al. Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the Anti-PD-1/L1 response. Adv Sci (Weinh). 2023;10(2): e2203973. https://doi.org/10.1002/advs.202203973.

Article  CAS  PubMed  Google Scholar 

He F, Zhang P, Liu J, et al. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol. 2023;79(2):362–77. https://doi.org/10.1016/j.jhep.2023.03.016.

Article  CAS  PubMed  Google Scholar 

Yang R, Gao W, Wang Z, et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis. Phytomedicine. 2024;122: 155135. https://doi.org/10.1016/j.phymed.2023.155135.

Article  CAS  PubMed